We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Liquidia Technologies Announces Extension of Collaboration with PATH

News   May 22, 2013

 
Liquidia Technologies Announces Extension of Collaboration with PATH
 
 
Advertisement
 

RELATED ARTICLES

Managing Immune Helper Cells in Elderly Could Improve Vaccine Efficacy

News

Scientists have taken a deeper look at how the immune system changes with age and their findings could help to make flu vaccines much more protective.

READ MORE

mRNA-1273 COVID-19 Vaccine Protects Airway in Nonhuman Primate Study

News

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.

READ MORE

Phase II/III Clinical Trial for COVID-19 Vaccine Begins at NYU Langone Health

News

The first U.S. patients have been dosed in a phase 2/3 clinical trial testing whether a lead mRNA vaccine candidate can prevent infection with the virus that causes COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE